Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Operating Expenses | 3,852 | 4,291 | 23,327 | 1,312 | 1,655 |
| Operating Income | -3,852 | -4,291 | -23,327 | -1,312 | -1,655 |
| Interest Expense | 0 | -8 | 3,054 | 3 | 5 |
| Other Income | 867 | 10,739 | -22,354 | -26 | -38 |
| Pre-tax Income | -2,985 | 6,456 | -48,736 | -1,341 | -1,697 |
| Net Income Continuous | -2,985 | 6,456 | -48,736 | -1,341 | -1,697 |
| Net Income | $-2,985 | $6,456 | $-48,736 | $-1,341 | $-1,697 |
| EPS Basic Total Ops | 0.00 | 28.00 | -120.00 | -4.00 | -4.00 |
| EPS Basic Continuous Ops | -5.07 | 26.74 | -124.69 | -3.71 | -4.70 |
| EPS Diluted Total Ops | 0.00 | 28.00 | -120.00 | -4.00 | -4.00 |
| EPS Diluted Continuous Ops | -5.07 | 26.74 | -124.69 | -3.71 | -4.70 |
| EBITDA(a) | $-3,843 | $-4,285 | $-23,324 | $-1,311 | $-1,654 |